Quick Takeaways
- GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share (OTLK).
- Disclosed ownership: 5%.
- Date of event: 30 Jun 2025.
GREAT POINT PARTNERS LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share (OTLK)
- Filing Manager
- GREAT POINT PARTNERS LLC
- Reporting Manager
- Great Point Partners, LLC
- Symbol
- OTLK
- Shares outstanding
- 44,488,978 shares
- Disclosed Ownership
- 2,220,000 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 17:15:38 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GREAT POINT PARTNERS LLC disclosed 5% ownership in Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share (OTLK) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 14 Aug 2025, 17:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Great Point Partners, LLC | 5% | 2,220,000 | 0 | 2,220,000 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D - Senior Managing Member | |
| Dr. Jeffrey R. Jay, M.D. | 5% | 2,220,000 | 0 | 2,220,000 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D | |
| Ms. Lillian Nordahl | 5% | 2,220,000 | 0 | 2,220,000 | /s/ Ms. Lillian Nordahl | Ms. Lillian Nordahl |